Showing results 1 to 7 of 7
| Title | Author(s) | Issue Date | |
|---|---|---|---|
3-weekly Daratumumab-imid-dexamethasone Is Highly Efficacious And Cost-effective In Relapsed/refractory Multiple Myeloma Proceeding/Conference:The 17th International Myeloma Workshop, 2019 | 2019 | ||
3-weekly Daratumumab-IMiD-dexamethasone is highly efficacious, hence financially affordable with enormous economic impacy for relapsed/ refractory Multiple Myeloma in less affluent counties Proceeding/Conference:The 24th Congress of European Haematology Association (EHA) | 2019 | ||
| 2021 | |||
A decade of Benzodiazepine and Z-drug use in Hong Kong: a longitudinal study Journal:The Lancet Regional Health - Western Pacific | 1-Jun-2025 | ||
| 2022 | |||
Opioid therapy for chronic non-cancer pain: guidelines for Hong Kong Journal:Hong Kong Medical Journal | 2016 | ||
Review of Newly Registered Oncology Drugs in Hong Kong Journal:Hong Kong Pharmaceutical Journal | 2016 |